To hear about similar clinical trials, please enter your email below
Trial Title:
Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care
NCT ID:
NCT05745285
Condition:
Leukemia
Lymphoma
Myeloma
Myelodysplastic Syndromes
Myeloproliferative Neoplasm
Conditions: Official terms:
Lymphoma
Leukemia
Myelodysplastic Syndromes
Myeloproliferative Disorders
Conditions: Keywords:
Blood cancer
Study type:
Interventional
Study phase:
N/A
Overall status:
Not yet recruiting
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Primary purpose:
Supportive Care
Masking:
None (Open Label)
Intervention:
Intervention type:
Other
Intervention name:
LLS Program
Description:
The intervention will be conducted virtually. Participants will receive LLS's free
patient and caregiver services including co-pay assistance, transportation and urgent
need assistance, a scholarship program for young adult patients and survivors, one-on-one
peer-to-peer support, online chats and support groups facilitated by clinical social
workers, and nutrition counseling with a registered dietician for 6 months.
Arm group label:
LLS Program and Usual Care Group
Summary:
The purpose of this study is to learn about the impact that the services and programs
provided by the Leukemia and Lymphoma Society have among patients with blood cancer, such
as access to care, quality of life, and financial burden.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Be currently receiving primary or relapse treatment for a diagnosis of leukemia,
lymphoma, myeloma, myelodysplastic syndromes (MDS), or myeloproliferative neoplasms
(MPN)
- Report experiencing at least one unmet need addressed by the LLS Program (i.e.,
medical care including second opinions, travel for care, clinical trial access,
financial and insurance needs, supportive programs, disease and treatment education)
- Not be currently participating in any LLS programs or services
- Be willing to be followed for 6 months
- Speak English or Spanish
Exclusion Criteria:
- Are not receiving primary or relapse treatment for a diagnosis of leukemia,
lymphoma, myeloma, myelodysplastic syndromes (MDS), or myeloproliferative neoplasms
(MPN)
- Are not experiencing unmet needs addressed by the LLS Program (i.e., medical care
including second opinions, travel for care, clinical trial access, financial and
insurance needs, supportive programs, disease and treatment education)
- Are currently participating in any LLS programs or services
- Are not willing to be followed for 6 months
- Do not speak English or Spanish.
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Sylvester Comprehensive Cancer Center
Address:
City:
Miami
Zip:
33136
Country:
United States
Contact:
Last name:
Madeline Krause, MSEd
Phone:
305-243-3329
Email:
mkrause@miami.edu
Investigator:
Last name:
Frank Penedo, PhD
Email:
Principal Investigator
Facility:
Name:
University of Chicago Comprehensive Cancer Center
Address:
City:
Chicago
Zip:
60637
Country:
United States
Contact:
Last name:
Mariam Nawas, MD
Phone:
773-702-6149
Email:
nawasm@bsd.uchicago.edu
Investigator:
Last name:
Mariam Nawas, MD
Email:
Principal Investigator
Facility:
Name:
Mays Cancer Center at UT Health San Antonio
Address:
City:
San Antonio
Zip:
78229
Country:
United States
Contact:
Last name:
Patricia Chalela, DrPH
Phone:
210-562-6513
Email:
chalela@uthscsa.edu
Investigator:
Last name:
Patricia Chalela, DrPH
Email:
Principal Investigator
Start date:
December 1, 2024
Completion date:
November 1, 2025
Lead sponsor:
Agency:
University of Miami
Agency class:
Other
Collaborator:
Agency:
The Leukemia and Lymphoma Society
Agency class:
Other
Source:
University of Miami
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05745285
